Skip to main content

Implementation of Targeted Total Body Irradiation as a Bone Marrow Transplant Conditioning Regimen: A Review

  • Chapter
  • First Online:
Total Marrow Irradiation

Abstract

Many hematologic malignancies require hematopoietic cell transplantation (HCT) during their course of treatment. Total body irradiation (TBI) has an important role in patients undergoing HCT. TBI induces immunosuppression to prevent the rejection of donor marrow. TBI is also used to eradicate malignant cells in sanctuary organs that are not reached by chemotherapy drugs. However, combined with chemotherapy, TBI is associated with significant toxicities. Targeted TBI has been shown to be able to reduce doses to normal organs, which predicts for reduced toxicities compared with standard TBI. Since the first total marrow irradiation (TMI) patient using intensity-modulated radiation therapy (IMRT) on Helical TomoTherapy was treated in 2005, many studies have been conducted and published. In this article, we review the practical aspects of targeted TBI implementation starting from patient positioning, immobilization, CT simulation, target delineation, plan optimization, dosimetry comparison, and quality assurance to treatment delivery. Recommendations on practical implementation to deliver targeted TBI are made with the intent to improve the planning and treatment process and to establish consistent and comparable treatment standards among institutions.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 79.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 99.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Ferrebee JW, Thomas ED. Factors affecting the survival of transplanted tissues. Am J Med Sci. 1958;235:369–86.

    Article  CAS  PubMed  Google Scholar 

  2. Schenken LL, Hagemann RF. Time/dose relationships in experimental radiation cataractogenesis. Radiology. 1975;117:193–8.

    Article  CAS  PubMed  Google Scholar 

  3. Van Dyk J, Keane TJ, Kan S, Rider WD, Fryer CJ. Radiation pneumonitis following large single dose irradiation: a re-evaluation based on absolute dose to lung. Int J Radiat Oncol Biol Phys. 1981;7:461–7.

    Article  PubMed  Google Scholar 

  4. Blaise D, Maraninchi D, Archimbaud E, Reiffers J, Devergie A, Jouet JP, Milpied N, Attal M, Michallet M, Ifrah N. Allogeneic bone marrow transplantation for acute myeloid leukemia in first remission: a randomized trial of a busulfan-cytoxan versus cytoxan-total body irradiation as preparative regimen: a report from the Group d’Etudes de la Greffe de Moelle Osseuse. Blood. 1992;79:2578–82.

    Article  CAS  PubMed  Google Scholar 

  5. Thomas BC, Stanhope R, Plowman PN, Leiper AD. Growth following single fraction and fractionated total body irradiation for bone marrow transplantation. Eur J Pediatr. 1993;152:888–92.

    Article  CAS  PubMed  Google Scholar 

  6. Leiper AD. Late effects of total body irradiation. Arch Dis Child. 1995;72:382–5.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Shank B. The balancing act: pneumonitis vs. relapse in cytoreductive regimens containing total body irradiation. Int J Radiat Oncol Biol Phys. 1996;36:261–2.

    Article  CAS  PubMed  Google Scholar 

  8. Curtis RE, Rowlings PA, Deeg HJ, Shriner DA, Socie G, Travis LB, Horowitz MM, Witherspoon RP, Hoover RN, Sobocinski KA, Fraumeni JFJ, Boice JDJ. Solid cancers after bone marrow transplantation. N Engl J Med. 1997;336:897–904.

    Article  CAS  PubMed  Google Scholar 

  9. Ringden O, Remberger M, Ruutu T, Nikoskelainen J, Volin L, Vindelov L, Parkkali T, Lenhoff S, Sallerfors B, Mellander L, Ljungman P, Jacobsen N. Increased risk of chronic graft-versus-host disease, obstructive bronchiolitis, and alopecia with busulfan versus total body irradiation: long-term results of a randomized trial in allogeneic marrow recipients with leukemia. Nordic Bone Marrow Transplantation Group. Blood. 1999;93:2196–201.

    Article  CAS  PubMed  Google Scholar 

  10. Socie G, Clift RA, Blaise D, Devergie A, Ringden O, Martin PJ, Remberger M, Deeg HJ, Ruutu T, Michallet M, Sullivan KM, Chevret S. Busulfan plus cyclophosphamide compared with total-body irradiation plus cyclophosphamide before marrow transplantation for myeloid leukemia: long-term follow-up of 4 randomized studies. Blood. 2001;98:3569–74.

    Article  CAS  PubMed  Google Scholar 

  11. Della Volpe A, Ferreri AJM, Annaloro C, Mangili P, Rosso A, Calandrino R, Villa E, Lambertenghi-Deliliers G, Fiorino C. Lethal pulmonary complications significantly correlate with individually assessed mean lung dose in patients with hematologic malignancies treated with total body irradiation. Int J Radiat Oncol Biol Phys. 2002;52:483–8.

    Article  PubMed  Google Scholar 

  12. Hasegawa W, Pond GR, Rifkind JT, Messner HA, Lau A, Daly AS, Kiss TL, Kotchetkova N, Galal A, Lipton JH. Long-term follow-up of secondary malignancies in adults after allogeneic bone marrow transplantation. Bone Marrow Transplant. 2005;35:51–5.

    Article  CAS  PubMed  Google Scholar 

  13. Bolling T, Kreuziger DC, Ernst I, Elsayed H, Willich N. Retrospective, monocentric analysis of late effects after total body irradiation (TBI) in adults. Strahlenther Onkol. 2011;187:311–5.

    Article  PubMed  Google Scholar 

  14. Wong JYC, Liu A, Schultheiss T, et al. Targeted total marrow irradiation using three-dimensional image-guided tomographic intensity-modulated radiation therapy: an alternative to standard total body irradiation. Biol Blood Marrow Transplant. 2006;12:306–15.

    Article  PubMed  Google Scholar 

  15. McCutchen KW, Watkins JM, Eberts P, Terwilliger LE, Ashenafi MS, Jenrette JM. Helical tomotherapy for total lymphoid irradiation. Radiat Med. 2008 Dec;26(10):622–6.

    Article  PubMed  Google Scholar 

  16. Stein A, Palmer J, Tsai NC, Al Malki MM, Aldoss I, Ali H, Aribi A, Farol L, Karanes C, Khaled S, Liu A, O'Donnell M, Parker P, Pawlowska A, Pullarkat V, Radany E, Rosenthal J, Sahebi F, Salhotra A, Sanchez JF, Schultheiss T, Spielberger R, Thomas SH, Snyder D, Nakamura R, Marcucci G, Forman SJ, Wong J. Phase I trial of total marrow and lymphoid irradiation transplantation conditioning in patients with relapsed/refractory acute leukemia. Biol Blood Marrow Transplant. 2017 Apr;23(4):618–24.

    Article  PubMed  PubMed Central  Google Scholar 

  17. Springer A, Hammer J, Winkler E, Track C, Huppert R, Böhm A, Kasparu H, Weltermann A, Aschauer G, Petzer AL, Putz E, Altenburger A, Gruber R, Moser K, Wiesauer K, Geinitz H. Total body irradiation with volumetric modulated arc therapy: dosimetric data and first clinical experience. Radiat Oncol. 2016 Mar 22;11:46.

    Article  PubMed  PubMed Central  Google Scholar 

  18. Sun R, Cuenca X, Itti R, Nguyen Quoc S, Vernant JP, Mazeron JJ, Jenny C, Chea M. First French experiences of total body irradiations using helical TomoTherapy. Cancer Radiother. 2017 Aug;21(5):365–72.

    Article  CAS  PubMed  Google Scholar 

  19. Bao Z, Zhao H, Wang D, Gong J, Zhong Y, Xiong Y, Deng D, Xie C, Liu A, Wang X, Liu H. Feasibility of a novel dose fractionation strategy in TMI/TMLI. Radiat Oncol. 2018 Dec 17;13(1):248.

    Article  PubMed  PubMed Central  Google Scholar 

  20. Cherpak A, Monajemi T, Chytyk-Praznik K, Mulroy L. Energy-dependent OAR sparing and dose conformity for total marrow irradiation of obese patients. J Appl Clin Med Phys. 2018 Sep;19(5):532–8.

    Article  PubMed  PubMed Central  Google Scholar 

  21. Lin SC, Hsieh PY, Shueng PW, Tien HJ, Wang LY, Hsieh CH. Total marrow irradiation as part of autologous stem cell transplantation for Asian patients with multiple myeloma. Biomed Res Int. 2013;2013:321762.

    PubMed  PubMed Central  Google Scholar 

  22. Fogliata A, Cozzi L, Clivio A, et al. Preclinical assessment of volumetric modulated arc therapy for total marrow irradiation. Int J Radiat Oncol Biol Phys. 2011;80:628–36.

    Article  PubMed  Google Scholar 

  23. Mancosu P, Navarria P, Castagna L, et al. Interplay effects between dose distribution quality and positioning accuracy in total marrow irradiation with volumetric modulated arc therapy. Med Phys. 2013;111713(1–7):40.

    Google Scholar 

  24. Corvò R, Zeverino M, Vagge S, Agostinelli S, Barra S, Taccini G, Van Lint MT, Frassoni F, Bacigalupo A. Helical tomotherapy targeting total bone marrow after total body irradiation for patients with relapsed acute leukemia undergoing an allogeneic stem cell transplant. Radiother Oncol. 2011 Mar;98(3):382–6.

    Article  PubMed  Google Scholar 

  25. Schultheiss TE, Wong J, Liu A, Olivera G, Somlo G. Image-guided total marrow and total lymphatic irradiation using helical tomotherapy. Int J Radiat Oncol Biol Phys. 2007;67:1259–67.

    Article  PubMed  Google Scholar 

  26. Shueng PW, Lin SC, Chong NS, Lee HY, Tien HJ, Wu LJ, Chen CA, Lee JJ, Hsieh CH. Total marrow irradiation with helical tomotherapy for bone marrow transplantation of multiple myeloma: first experience in Asia. Technol Cancer Res Treat. 2009 Feb;8(1):29–38.

    Article  PubMed  Google Scholar 

  27. Wilkie JR, Tiryaki H, Smith BD, Roeske JC, Radosevich JA, Aydogan B. Feasibility study for linac-based intensity modulated total marrow irradiation. Med Phys. 2008;35:5609–18.

    Article  PubMed  Google Scholar 

  28. Jiang B, Dai J, Zhang Y, Zhang K. Feasibility study of a novel rotational and translational method for linac-based intensity modulated total marrow irradiation. Technol Cancer Res Treat. 2012;11(3):237–47.

    Article  PubMed  Google Scholar 

  29. Jiang Z, Jia J, Yue C, Pang Y, Liu Z, Ouyang L, Li H, Zhang J, Wen T, Li J, Li Z, Wang Y, Xiao Y, Xiao H. Haploidentical hematopoietic SCT using helical tomotherapy for total-body irradiation and targeted dose boost in patients with high-risk/refractory acute lymphoblastic leukemia. Bone Marrow Transplant. 2018;53(4):438–48.

    Article  CAS  PubMed  Google Scholar 

  30. Mancosu P, Navarria P, Castagna L, Reggiori G, Stravato A, Gaudino A, Sarina B, Tomatis S, Scorsetti M. Plan robustness in field junction region from arcs with different patient orientation in total marrow irradiation with VMAT. Phys Med. 2015;31(7):677–82.

    Article  PubMed  Google Scholar 

  31. Lou X, Xia TY, Chen H. Improved clinical outcome after total marrow irradiation conditioning stem cell transplantation for hematologic malignancies. In: Wong J, Hui SK, editors. Total marrow irradiation. New York: Springer; 2020.

    Google Scholar 

  32. Aydogan B, Yeginer M, Kavak GO, Fan J, Radosevich JA, Gwe-Ya K. Total marrow irradiation with RapidArc volumetric arc therapy. Int J Radiat Oncol Biol Phys. 2011;81:592–9.

    Article  PubMed  Google Scholar 

  33. Han C, Schultheisss TE, Wong JYC. Dosimetric study of volumetric modulated arc therapy fields for total marrow irradiation. Radiother Oncol. 2012;102:315–20.

    Article  PubMed  Google Scholar 

  34. Patel P, Aydogan B, Koshy M, Mahmud D, Oh A, Saraf SL, Quigley JG, Khan I, Sweiss K, Mahmud N, Peace DJ, DeMasi V, Awan AM, Weichselbaum RR, Rondelli D. Combination of linear accelerator-based intensity-modulated total marrow irradiation and myeloablative fludarabine/busulfan: a phase I study. Biol Blood Marrow Transplant. 2014;20(12):2034–41.

    Article  CAS  PubMed  Google Scholar 

  35. Rosenthal J, Wong J, Stein A, Qian D, Hitt D, Naeem H, Dagis A, Thomas SH, Forman S. Phase 1/2 trial of total marrow and lymph node irradiation to augment reduced-intensity transplantation for advanced hematologic malignancies. Blood. 2011;117(1):309–15.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  36. Jensen LG, Stiller T, Wong JYC, Palmer J, Stein A, Rosenthal J. Total marrow lymphoid irradiation/fludarabine/melphalan conditioning for allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transplant. 2018;24(2):301–7.

    Article  CAS  PubMed  Google Scholar 

  37. Hui SK, Verneris MR, Higgins P, Gerbi B, Weigel B, Baker SK, Fraser C, Tomblyn M, Dusenbery K. Helical tomotherapy targeting total bone marrow - first clinical experience at the University of Minnesota. Acta Oncol. 2007;46(2):250–5.

    Article  PubMed  Google Scholar 

  38. Miften M, Olch A, Mihailidis D, Moran J, Pawlicki T, Molineu A, Li H, Wijesooriya K, Shi J, Xia P, Papanikolaou N, Low DA. Tolerance limits and methodologies for IMRT measurement-based verification QA: Recommendations of AAPM Task Group No. 218. Med Phys. 2018;45(4):e53–83.

    Article  PubMed  Google Scholar 

  39. Mancosu P, Navarria P, Reggiori G, Cozzi L, Fogliata A, Gaudino A, Lobefalo F, Paganini L, Palumbo V, Sarina B, Stravato A, Castagna L, Tomatis S, Scorsetti M. In-vivo dosimetry with Gafchromic films for multi-isocentric VMAT irradiation of total marrow lymph-nodes: a feasibility study. Radiat Oncol. 2015;10:86.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to A. Liu .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Liu, A., Han, C., Neylon, J. (2020). Implementation of Targeted Total Body Irradiation as a Bone Marrow Transplant Conditioning Regimen: A Review. In: Wong, J., Hui, S. (eds) Total Marrow Irradiation. Springer, Cham. https://doi.org/10.1007/978-3-030-38692-4_2

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-38692-4_2

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-38691-7

  • Online ISBN: 978-3-030-38692-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics